Former Editorial Board
Joachim G. Aerts, MD, PhD
Department of Pulmonary Diseases, Amphia Hospital, Breda, The Netherlands; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Myung-Ju Ahn, MD
Professor
Division of Hemato-Oncology
Department of Medicine
Sungkyunkwan University School of Medicine
Seoul, Korea
Luca Ampollini, MD, PhD
Thoracic Surgery, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy
Oscar Arrieta, MD, MSc
Thoracic Oncology Unit, Instituto Nacional de Cancerología de México (INCan), Mexico
David Ball, MB, BS, MD, FRANZCR
Deputy Director of Radiation Oncology & Cancer Imaging, Chair of Lung Service, Peter MacCallum Cancer Centre, Melbourne, Australia
Fiona Blackhall
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Institute of Cancer Sciences, University of Manchester, Manchester, UK
Michael Boyer, MD
Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Elisabeth Brambilla
Centre Hospitalier Universitaire de Grenoble, Département d'Anatomie et Cytologie Pathologiques, Grenoble, France
Emilio Bria, MD
Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; Medical Oncology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
Lauren Byers, MD
Associate Professor, Department of Thoracic/Head & Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA
Federico Cappuzzo, MD
Director of Medical Oncology, AUSL della Romagna-Ravenna, Italy
Jianhua Chang
Department of Oncology, Cancer Hospital Affiliated to Fudan University, Shanghai, China
Aadel A. Chaudhuri, MD, PhD
Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA
Jun Chen
Department of Medical Oncology, The Second Affiliated Hospital, Dalian Medical University, Dalian, China
Chang Chen, MD, PhD
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
Caroline Chiles
Department of Radiology, Wake Forest University Health Sciences Center, Winston-Salem, North Carolina, USA
William Chi-shing Cho
Queen Elizabeth Hospital, Hong Kong, China
J. Isabelle Choi
Radiation Oncology, California Protons Cancer Therapy Center, San Diego, California, USA
Jin-Haeng Chung
Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
Wendy A. Cooper
Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Daniel B. Costa
Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Sanja Dacic, MD, PhD
Department of Pathology, University of Pittsburgh, PUH C-608, 200 Lothrop Street, Pittsburgh, PA 15213, USA
Xiaorong Dong
Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Yun Fan
Department of Thoracic Oncology, Zhejiang Tumor Hospital, Hangzhou, Zhejiang, China
Wenfeng Fang
Department of Internal Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Anna F. Farago, MD, PhD
Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA
John K. Field, MA, PhD, BDS, FRCPath
Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Liverpool, UK
Shirish Madhav Gadgeel, MD
Professor, Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, USA
Justin F. Gainor
Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
David R. Gandara, MD
University of California Davis Comprehensive Cancer Center, Sacramento, California, USA
Adi F. Gazdar
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA; Departments of Pathology, UT Southwestern Medical Center, Dallas, TX, USA
Akihiko Gemma, MD (Medical Oncology)
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine,
President of Nippon Medical School, Tokyo, Japan
Vassilis Georgoulias MD, PhD
Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Greece; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
Jonathan W. Goldman, MD
Associate Professor, UCLA Hematology & Oncology
Associate Director of Drug Development
Director of Clinical Trials in Thoracic Oncology, California, USA
Peter Goldstraw, MD, FRCS
Academic Department of Thoracic Surgery, Royal Brompton Hospital, Imperial College London, London, UK
Cesare Gridelli, MD
Division of Medical Oncology, ‘S. G. Moscati’ Hospital, Avellino, Italy
Renhua Guo
Department of Oncology, Jiangsu Provincial People's Hospital, Jiangsu, China
Yong Guo
Department of Oncology, First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Zhejiang, China
Balazs Halmos, MD
Professor of Clinical Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, New York, USA
Zhengxiang Han
Department of Oncology, Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
Takeshi Hanagiri, MD, PhD
Second Department of Surgery, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Samir Hanash, MD, PhD
The University of Texas MD Anderson Cancer Center, Houston, Texas;
Director, Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer;
Evelyn & Sol Rubenstein Distinguished Chair for Cancer Prevention;
Professor, Clinical Cancer Prevention-Research;
Professor, Translational Molecular Pathology
Yayi He, MD, PhD
Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
Chuong D. Hoang, MD
Section of Thoracic Surgery, National Institutes of Health, National Cancer Institute, Center for Cancer Research, and The Clinical Center, Bethesda, USA
Paul Hofman, MD, PhD
Université Côte d’Azur, CHU Nice, FHU OncoAge, Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France;
Université Côte d’Azur, CNRS, INSERM, IRCAN, FHU OncoAge, Team 4, Nice, France;
Université Côte d’Azur, CHU Nice, FHU OncoAge, Hospital-Integrated Biobank, Nice, France
Maurizio V. Infante, MD
Head of Thoracic Surgery Dept. University and Hospital Trust, Verona, Italy
Da Jiang
Department of Oncology, the Fourth Affiliated Hospital of Hebei Medical University, Hebei, China
Xiao-dong Jiang, MD, PhD
Director of Oncology Department and Radiotherapy Centre, Chief Physician, No.1 People’s Hospital of Lianyungang City (3A), Jiangsu, China
Tao Jiang, PhD
Medical oncology, Shanghai Pulmonary Hospital, Thoracic Oncology Center, Tongji University School of Medicine, Shanghai, China
Kazuhiro Kakimi, MD, PhD
Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, Japan
Medical Sciences Innovation Hub Program, RIKEN, Tokyo, Japan
Gregory P. Kalemkerian, MD, FACP
Professor, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA
Niki Karachaliou, MD
Pangaea Biotech, USP Instituto Universitario Dexeus, Barcelona, Spain
Edward S. Kim, MD
Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA
Yoshihisa Kobayashi, MD, PhD
Department of Thoracic Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
Takashi Kohno, PhD
Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan
Feng-Ming (Spring) Kong, MD, PhD, Fellow of American College of Radiology
Professor of Radiation Oncology and Medical and Molecular Genetics, Indiana University; Director of Clinical Research and Clinical Trial, Department of Radiation Oncology, Co-Leader of Thoracic Oncology Program, Melvin and Bren Simon Cancer Center, Indianapolis, USA
Alexander Sasha Krupnick, MD
Department of Surgery, University of Virginia, Charlottesville, Virginia, USA
Choon-Taek Lee, MD, PhD
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Bundang-Gu, Seongnam, Gyeonggi-do, Republic of Korea
Antonin Levy, MD, PhD (Radiation Oncology)
Department of Radiation Oncology, Gustave Roussy Cancer Centre, Villejuif, Université Paris-Saclay, France
Lu Li, MD
Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China
Xiaohua Liang
Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China
Ying Liang, MD, PhD
Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
Yang Ling, MD
Changzhou Cancer Hospital, Affiliated of Soochow University, Changzhou, China
Chunling Liu
Department of Respiratory Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China
Jiang Liu
Department of Oncology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
Jiwei Liu
Department of Oncology, First Affiliated Hospital of Dalian Medical Universtiy, Dalian, China
Hongbing Liu, MD, PhD
Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
William W. Lockwood, MD, PhD
Integrative Oncology Department, BC Cancer
Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
You Lu
Department of Thoracic Oncology, West China Hospital of Sichuan University, Sichuan, China
Tangfeng Lv
Department of Respiratory Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
Zhiyong Ma
Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
Patrick C. Ma, MD, MS
WVU Cancer Institute, West Virginia University, Morgantown, West Virginia, USA
David MacPherson, PhD
Fred Hutchinson Cancer Research Center, Division of Human Biology, Seattle, Washington, USA
Jyoti Malhotra, MD, MPH
Assistant Professor, Medical Oncology
Co-leader, Thoracic Oncology Disease Specific Group
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA
Hirva Mamdani, MD
Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan, USA
Christian Manegold, MD
Department of Surgery, Interdisciplinary Thoracic Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
Yukinori Matsuo, MD, PhD
Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Giulio Metro, MD
Department of Medical Oncology, Santa Maria della Misericordia Hospital, AOU di Perugia, Italy
John D. Minna, M.D.
Director of the Hamon Center for Therapeutic Oncology Research, Professor of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
Tetsuya Mitsudomi, MD
Department of Surgery, Division of Thoracic Surgery, Kinki University Faculty of Medicine, Osaka-Sayama, Japan
James L. Mulshine, MD
Department of Internal Medicine, Associate Provost for Research and Vice President, Rush University, Chicago, USA
Yasuhiko Nishioka, MD, PhD
Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
Nicola Normanno, MD
Cell Biology and Biotherapy Unit, National Cancer Institute "Pascale Foundation," Institute of Hospitalization and Scientific Care (IRCCS), Naples, Italy
Silvia Novello, MD, PhD
Oncology Department-Thoracic Oncology Unit, AOU San Luigi, University of Turin, Italy
Raymond U. Osarogiagbon, MBBS, FACP
Multidisciplinary Thoracic Oncology Program, Baptist Centers for Cancer Care, Memphis, TN, USA
Taofeek K. Owonikoko, MD, PhD
Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA
Kenneth O’Byrne
Consultant Medical Oncologist, Princess Alexandra Hospital (PAH)/Queensland University of Technology, Brisbane, Australia
Joshua D. Palmer, MD
Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
Yueyin Pan
Department of Oncology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
Luis Paz-Ares, MD, PhD
Chair of the Medical Oncology Department at the Hospital Universitario 12 de Octubre Associate Professor at the Universidad Complutense de Madrid;
Head of the Lung Cancer Unit at the CNIO (Spanish National Cancer Research Center) President of ASEICA (Spanish Association of Cancer Research), Madrid, Spain
Nathan A. Pennell, MD, PhD
Director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
Helmut H. Popper, MD
Prof. of Pathology, Department of Pathology, Medical University of Graz, Austria
Luis E. Raez, MD, FACP, FCCP
Chief, Hematology/Oncology & Medical Director of Memorial Cancer Institute (MCI)
Director, Thoracic Oncology Program, Florida, USA
Suresh S. Ramalingam, MD
Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
Neal E. Ready, MD, PhD
Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina, USA
Jordi Remon, MD
Medical Oncology Department, Centro Integral Oncología Clara Campal Barcelona-HM Delfos, Barcelona, Spain
Christian D. Rolfo
Professor in Oncology Antwerp University Hospital, Belgium
Giulio Rossi, MD, PhD
Doctor Rossi is currently Director of the Pathology Units, Azienda USL della Romagna, Hospital St. Maria delle Croci (Ravenna, Italy) and Hospital “Degli Infermi” (Rimini, Italy)
Antonio Rossi, Sr. M.D.
Oncology Centre of Excellence, Therapeutic Science & Strategy Unit, IQVIA, Milan, Italy.
Charles M. Rudin, MD, PhD
Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, USA
Jimmy Ruiz, MD
Department of Medicine (Hematology & Oncology), Wake Forest School of Medicine, Winston-Salem; W.G. (Bill) Hefner Veteran Administration Medical Center, Cancer Center, Salisbury, North Carolina, USA
Manuel Salto-Tellez, MD-LMS, FRCPath, FRCPI
Chair, Molecular Pathology at Queen’s University Belfast (QUB)
Director, QUB’s Precision Medicine Centre of Excellence, Belfast, UK
Giorgio Vittorio Scagliotti, MD, PhD
Chief of the Medical Oncology Division at the S. Luigi Hospital, Orbassano (Torino), Head of the Department of Oncology at University of Torino, Italy
Gerald Schmid-Bindert, MD
Department of Surgery, Heidelberg University Medical Center Mannheim, Mannheim, Germany
Suresh Senan, MRCP, FRCR, PhD
Department of Radiation Oncology, University Medical Center, Amsterdam, The Netherlands
Yoshihisa Shimada, MD, PhD.
Department of Thoracic Surgery, Tokyo Medical University, Nishishinjuku, Shinjuku-ku, Tokyo, Japan
Vani Nath Simmons, PhD
Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, Florida; Department of Psychology, University of South Florida, Tampa, Florida; Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA
Ben J. Slotman, MD, PhD
Professor and Chairman, Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands
Giulia M. Stella, MD, PhD
Department of Hematological, Pneumological and Cardiovascular Sciences - Section of Pneumology, University and Fondazione IRCCS Policlinico, Pavia, Italy
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Heidelberg, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Thomas E. Stinchcombe
Thoracic Oncology Program, Duke University, Durham NC
Emily Stone
Consultant Respiratory Physician and Acting Head of Thoracic Medicine within the Department of Lung Transplantation and Thoracic Medicine at St Vincent’s Hospital, Sydney, Australia
Stephen G. Swisher
Head, Division of Surgery, Professor and Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, Department of Thoracic & Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center,Houston, TX, USA
Masayuki Takeda, MD, PhD
Professor, Department of Cancer Genomics and Medical Oncology, Nara Medical University, Nara, Japan
Nagio Takigawa, MD, PhD
Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan
Min Tao
Department of Oncology, First Affiliated Hospital of Suzhou University, Suzhou, China
Marcello Tiseo
Medical Oncology Unit, University Hospital of Parma, Parma, Italy
Gouji Toyokawa
Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan
Peter Ujhazy, MD, PhD
Deputy Associate Director, Translational Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, USA
Hidetaka Uramoto, MD, PhD
Second Department of Surgery (chest surgery), School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Japan
Paul Jules Van Houtte
Department Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium
Paul van Schil, MD
Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium
Nico van Zandwijk, MD
Asbestos Diseases Research Institute, University of Sydney Bernie Banton Centre, Concord, New South Wales, Australia
Alain Vergnenegre, MD, PhD
Service de l’Information Médicale et de l’Evaluation, Service de Pathologie Respiratoire et d’Allergologie, CHU Dupuytren, Limoges Cedex, France
Heather A. Wakelee, MD (Medical Oncology)
Department of Medical Oncology, Stanford Cancer Institute, Stanford, California, USA
Jie Wang
Department of Internal Medicine, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
Zhehai Wang
Department of Internal Medicine-Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China
Kenneth D. Ward, PhD
School of Public Health, University of Memphis, Memphis TN, USA
Graham Warren MD, PhD
Associate Professor, Vice Chairman for Research in Radiation Oncology, Department of Radiation Oncology, Department of Cell and Molecular, Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
Jia Wei, MD, PhD
The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, P.R China
Glen J. Weiss, MD, MBA
SOTIO Biotech Inc; Associate Professor of Medicine at UMass Chan Medical School
Frederik Wenz, MD
Department of Radiation Oncology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany
John White
Lead Macmillan Lung Cancer Nurse Specialist at the Leeds Teaching Hospitals NHS Trust, UK
Juergen Wolf, MD
Dep. I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Köln Bonn, Köln, Germany
Lin Wu
Second Department of Chest Medicine, Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, China
Yi-Long Wu
Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
Congying Xie
Department of Radiotherapy and Chemotherapy, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Yaping Xu
Department of Radiotherapy, Shanghai Pulmonary Hospital, Shanghai, China
Xiaolong Yan, MD, PHD
Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xian, Shanxi, China
Yang Yang, MD
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
Yu Yao
Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Timothy A. Yap, MD, PhD
Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Yuansheng Zang
Department of Oncology, Shanghai Changzheng Hospital, Shanghai, China
Paul Zarogoulidis, MD, PhD
Pulmonary Department-Oncology Unit, "G.Papanikolaou" General Hospital, Aristotle University Of Thessaloniki, Thessaloniki , Greece
Baihong Zhang
Department of Oncology, Lanzhou General Hospital, Lanzhou, China
Xiaochun Zhang
Department of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
Hong Zhao
Department of Oncology, PLA General Hospital, Beijing, China
Wenzhao Zhong, MD, PhD (Biomarker)
Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
Wu Zhuang
Department of Thoracic Oncology, Fujian Provincial Cancer Hospital, Fujian, China